IGARASHI Masao

No ORCID on file · 430 papers in corpus
1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1992

Disclosed is a use of danazol for vaginal administration in a form of powder, tablet, suppository, capsule or liquid, or for parenteral and non-vaginal administration in a form of a solution, the content or concentration of danazol is speci…

1989

A topical drug delivery system comprises as a matrix base, danazol retained therein, and optionally a release-promoting agent. Such a system is more effective than oral administration of danazol in the shrinkage of endometriosis tissue, and…

1989

A topical drug delivery system comprises as a matrix base, danazol retained therein, and optionally a release-promoting agent. Such a system is more effective than oral administration of danazol in the shrinkage of endometriosis tissue, and…

1989

A topical drug delivery system comprises as a matrix base, danazol retained therein, and optionally a release-promoting agent. Such a system is more effective than oral administration of danazol in the shrinkage of endometriosis tissue, and…

1989

A topical drug delivery system comprises as a matrix base, danazol retained therein, and optionally a release-promoting agent. Such a system is more effective than oral administration of danazol in the shrinkage of endometriosis tissue, and…

1989

A topical drug delivery system comprises as a matrix base, danazol retained therein, and optionally a release-promoting agent. Such a system is more effective than oral administration of danazol in the shrinkage of endometriosis tissue, and…

1989

A topical drug delivery system comprises as a matrix base, danazol retained therein, and optionally a release-promoting agent. Such a system is more effective than oral administration of danazol in the shrinkage of endometriosis tissue, and…